SERUM ERYTHROPOIETIN (SEPO) TESTING, LEVELS, AND SUBSEQUENT TREATMENT PATTERNS FOR TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)

被引：0
|
作者：
Gerds, A. [1 ]
Binder, G. [2 ]
Fliss, A. [2 ]
McGuire, M. [2 ]
Hawthorne, S. [3 ]
King-Concialdi, K. [3 ]
DiBonaventura, M. [3 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Celgene Corp, Summit, NJ USA
[3] Kantar Hlth, New York, NY USA
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1917
引用
收藏
页码：772 / 773
页数：2
相关论文
共 50 条
  • [31] Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels
    Santini, Valeria
    Almeida, Antonio
    Giagounidis, Aristoteles
    Skikne, Barry
    Beach, C. L.
    Weaver, Jerry
    Tu, Nora
    Fenaux, Pierre
    LEUKEMIA & LYMPHOMA, 2020, 61 (06) : 1475 - 1483
  • [32] Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes
    Lin, Y.
    Saskin, A.
    Wells, R. A.
    Lenis, M.
    Mamedov, A.
    Callum, J.
    Buckstein, R.
    VOX SANGUINIS, 2017, 112 (01) : 79 - 86
  • [33] Patterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromes
    DeZern, Amy E.
    Binder, Gary
    Rizvi, Syed
    Corvino, Frank A.
    Arikian, Steven R.
    Surinach, Andy
    Lee, Jianyi
    Smith, B. Douglas
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2649 - 2656
  • [34] Real-World Treatment Patterns and Transfusion Burden Among US Patients with Newly Diagnosed Myelodysplastic Syndromes (MDS)
    Mukherjee, Sudipto
    Slabaugh, S. Lane
    Copher, Ronda
    Johnson, Jonathan
    Buzinec, Paul
    Mearns, Elizabeth S.
    BLOOD, 2019, 134
  • [35] Persistent Red Blood Cell (RBC) Transfusion Is Associated with Increased Mortality Risk in Transfusion-Dependent (TD) Patients with Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS plus )
    Buckstein, Rena
    Zhu, Nancy
    Keating, Mary-Margaret
    Leber, Brian
    Chodirker, Lisa
    Sabloff, Mitchell
    Cristou, Grace
    Leitch, Heather A.
    St Hilaire, Eve
    Finn, Nicholas
    Yee, Karen W. L.
    Elemary, Mohamed
    Banerji, Versha
    Lenis, Martha
    Kirubananthaan, Aksharh
    Liu, Fei Fei
    Tang, Derek
    Westcott, Chris
    Huang, Vicky Wei-Hsuen
    Wang, Di
    Cameron, Chris
    Morison, Jessica
    Spin, Paul
    Mamedov, Alexandre
    BLOOD, 2019, 134
  • [36] Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes
    Mukherjee, Sudipto
    Dong, Weichuan
    Schiltz, Nicholas K.
    Stange, Kurt C.
    Cullen, Jennifer
    Gerds, Aaron T.
    Carraway, Hetty E.
    Singh, Abhay
    Advani, Anjali S.
    Sekeres, Mikkael A.
    Koroukian, Siran M.
    ONCOLOGIST, 2023, 28 (10): : 901 - 910
  • [37] Molecular and Diagnostic Testing Patterns in Elderly Patients with Myelodysplastic Syndromes (MDS) in the Connect® MDS/AML Disease Registry
    George, Tracy I.
    Cogle, Christopher R.
    Garcia-Manero, Guillermo
    Grinblatt, David L.
    Komrokji, Rami S.
    Kurtin, Sandra E.
    Maciejewski, Jaroslaw P.
    Savona, Michael R.
    Scott, Bart L.
    Sekeres, Mikkael A.
    Steensma, David P.
    Flick, E. Dawn
    Kiselev, Pavel
    Louis, Chrystal U.
    Nifenecker, Melissa
    Swern, Arlene S.
    Foucar, Kathryn
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S315 - S315
  • [38] Optimising management of deferasirox therapy for patients with transfusion-dependent thalassaemia and lower-risk myelodysplastic syndromes
    Kattamis, Antonis
    Aydinok, Yesim
    Taher, Ali
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 272 - 282
  • [39] Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes
    Lucijanic, Marko
    Lovrinov, Miran
    Skelin, Marko
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (07) : 595 - 595
  • [40] Serum erythropoietin (EPO) levels correlate with survival and independently predict response to EPO treatment in patients with myelodysplastic syndromes
    Wallvik, J
    Stenke, L
    Bernell, P
    Nordahl, G
    Hippe, E
    Hast, R
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 68 (03) : 180 - 186
12345